Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: Quantification of conidial kill at the single-cell level

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 10, 1998, Pages 2569-2575

  Jahn, Bernhard ^a,c   Rampp, Albert ^b   Dick, Christian ^a   Jahn, Andreas ^a   Palmer, Michael ^a   Bhakdi, Sucharit ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b LabDiv II (VetMed)   (Germany)

^c Inst of Med Microbiol and Hygiene   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROPIDIUM IODIDE; STREPTOLYSIN O; TOXIN;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; CYTOFLUOROMETRY; DOSE RESPONSE; DRUG ACCUMULATION; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0031691296     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.10.2569     Document Type: Article

References (39)

1. Benson, J. M., and M. C. Nahata. 1988. Clinical use of systemic antifungal agents. Clin. Pharm. 7:424-438.
2. Beyer, J., G. Barzen, G. Risse, C. Weyer, K. Miksits, K. Dullenkopf, D. Huhn, and W. Siegert. 1493. Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 37:1367-1369.
3. Bhakdi, S., U. Weller, I. Walev, E. Martin, D. Jonas, and M. Palmer. 1993. A guide to the use of pore-forming toxins for controlled permeabilization of cell membranes. Med. Microbiol. Immunol. Berlin 182:167-175.
4. Bouchara, J. P., G. Tronchin, G. Larcher, and D. Chabasse. 1995. The search for virulence determinants in Aspergillus fumigatus. Trends. Microbiol. 3:327-330.
5. Denning, D. W. 1994. Invasive aspergillosis in immunocompromised patients. Curr. Opin. Infect. Dis. 7:456-462.
6. Edmonds, L. C., L. Davidson, and J. S. Bertino. 1991. Effect of variation in infusion time and macrophage blockade on organ uptake of amphotericin B-deoxycholate. J. Antimicrob. Chemother. 28:919-924.
7. Ellis, M. E., A. A. al-Hokail, H. M. Clink, M. A. Padmos, P. Ernst, D. G. Spence, W. N. Tharpe, and V. F. Hillier. 1992. Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B. Antimicrob. Agents Chemother. 36:172-179.
8. Fraser, I. S., and D.W. Denning. 1993. Empiric amphotericin B therapy: the need for a reappraisal. Blood Rev. 7:208-214.
9. Garn, H., H. Krause, V. Enzmann, and K. Drossler. 1994. An improved MTT assay using the electron-coupling agent menadione. J. Immunol. Methods 168:253-256.
10. Griffin, D. H. 1994. Fungal physiology, p. 23-62. Wiley-Liss, New York, N.Y.
11. Hoeprich, P. D. 1992. Clinical use of amphotericin B and derivatives: lore, mystique, and fact. Clin. Infect. Dis. 14(Suppl. 1):S114-S119.
12. Holden, D. W., C. M. Tang, and J. M. Smith. 1994. Molecular genetics of Aspergillus pathogenicity. Antonie Leeuwenhoek 65:251-255.
13. Jahn, B., E. Martin, A. Stüben, and S. Bhakdi. 1995. Susceptibility testing of Candida albicans and Aspergillus species by a simple microtitcr menadioneaugmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. J. Clin. Microbiol. 33:661-667.
14. Jahn, B., A. Stüben, and S. Bhakdi. 1996. Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar Blue tests. J. Clin. Microbiol. 34:2039-2041.
15. Kramer, M. R., S. E. Marshall, V. A. Starnes, P. Gamberg, Z. Amitai, and J. Theodore. 1993. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch. Intern. Med. 153:2010-2016.
16. Martin, E., and S. Bhakdi. 1991. Quantitative analysis of opsonophagocytosis and of killing of Candida albicans by human peripheral blood leukocytes by using flow cytometry. J. Clin. Microbiol. 29:2013-2023.
17. Martin, E., F. Maier, and S. Bhakdi. 1994. Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum. Antimicrob. Agents Chemother. 38:1331-1338.
18. Martin, E., A. Stüben, A. Gorz, U. Weller, and S. Bhakdi. 1994. Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans. Antimicrob. Agents Chemother. 38:13-22.
19. McWhinney, P. H., C. C. Kibbler, M. D. Hamon, O. P. Smith, L. Gandhi, L. A. Berger, R. K. Walesby, A. V. Hoffbrand, and H. G. Prentice. 1993. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin. Infect. Dis. 17:397-404.
20. Meier-Osusky, I., G. Schoedon, F. Blauer, M. Schneemann, and A. Schaffner. 1996. Comparison of the antimicrobial activity of deactivated human macrophages challenged with Aspergillus fumigatus and Listeria monocytogenes. J. Infect. Dis. 174:651-654.
21. Musial, C. E., F. R. Cockerill, and G. D. Roberts. 1988. Fungal infections of the immunocompromised host: clinical and laboratory aspects. Clin. Microbiol. Rev. 1:349-364.
22. Perfect, J. R., D. L. Granger, and D. T. Durack. 1987. Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells. J. Infect. Dis. 156:316-323.
23. Purcell, I. F., and P. A. Corris. 1995. Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema. Thorax 50:1321-1323.
24. Robertson, M. D., K. M. Kerr, and A. Seaton. 1989. Killing of Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heat-labile serum components. J. Med. Vet. Mycol. 27:295-302.
25. Roilides, E., K. Uhlig, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1993. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun. 61: 4870-4877.
26. Roilides, E., A. Holmes, C. Blake, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1994. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma. J. Infect. Dis. 170:894-899.
27. Roilides, E., A. Dimitriadou, I. Kadiltsoglou, T. Sein, J. Karpouzas, P. A. Pizzo, and T. J. Walsh. 1997. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Immunol. 158:322-329.
28. Rousey, S. R., S. Russler, M. Gottlieb, and R. C. Ash. 1991. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. Am. J. Med. 91:484-492.
29. Schaffner, A. 1985. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J. Clin. Invest. 76:1755-1764.
30. Schaffner, A. 1992. Host defense in aspergillosis, p. 98-112. In J. E. Benett, R. J. Hay, and P. K. Peterson (ed.), New strategies in fungal disease. Churchill Livingstone, Edinburgh, United Kingdom.
31. Schaffner, A. 1994. Macrophage-Aspergillus interactions. Immunol. Ser. 60: 545-552.
32. Schaffner, A., H. Douglas, A. I. Braude, and C. E. Davis. 1983. Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect. Immun. 42:1109-1115.
33. Shihabi, Z. K., B. L. Wasilauskas, and J. E. Peacock. 1988. Serum amphotericin-B assay by scanning spectrophotometry. Ther. Drug Monit. 10:486-489.
34. Stephan, J. L., V. Vlekova, F. Le Deist, S. Blanche, J. Donadieu, G. De Saint Basile, A. Durandy, C. Griscelli, and A. Fischer. 1993. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J. Pediatr. 123:564-572.
35. Tanke, H. J., P. W. van der Linden, and J. Langerak. 1982. Alternative fluorochromes to ethidium bromide for automated read out of cytotoxicity tests. J. Immunol. Methods 52:91-96.
36. van Etten, E. W., N. E. van de Rhee, K. M. van Kampen, and I. A. Bakker-Woudenberg. 1991. Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans. Antimicrob. Agents Chemother. 35:2275-2281.
37. Washburn, R. G., J. I. Gallin, and J. E. Bennett. 1987. Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and-independent pathways. Infect. Immun. 55:2088-2092.
38. Washburn, R. G., C. H. Hammer, and J. E. Bennett. 1986. Inhibition of complement by culture supernatants of Aspergillus fumigatus. J. Infect. Dis. 154:944-951.
39. Weller, U., L. Muller, M. Messner, M. Palmer, A. Valeva, J. Tranum-Jensen, P. Agrawal, C. Biermann, A. Dobereiner, M. A. Kehoe, and S. Bhakdi. 1996. Expression of active streptolysin O in Escherichia coli as a mallose-binding-protein-streptolysin-O fusion protein. The N-terminal 70 amino acids are not required for hemolytic activity. Eur. J. Biochem. 236:34-39.